Podcasts about Intuitive Surgical

"A good sales methodology isn't about scripts—it's about teaching repeatable A-player behaviors in a way that reps can personalize and internalize. That's how you turn process into performance." — Paul Butterfield Check Out These Highlights: In my experience, when sales results stall, many leaders default to pressure. But in complex, high-stakes deals, pressure erodes trust and weakens influence. My guest is going to break down how top-performing sellers operate as leaders, not closers—building strategic connections, creating urgency without force, and guiding buyers through moments of uncertainty. This conversation offers a practical framework for strengthening accountability, resilience, and trust so sales teams perform consistently without burning relationships. About Whitney Faires: Whitney Faires is an executive coach, keynote speaker, and former Fortune 500 leader with 20 years of experience in healthcare and sales leadership. She scaled a two-billion-dollar international finance portfolio at Intuitive Surgical and now helps leaders build resilient, high-performing teams. Whitney is known for translating real-world leadership pressure into practical tools that drive accountability, trust, and sustainable performance. How to Get in Touch with Whitney Faires: Website:  https://whitneyfaires.com/ Email: whitney@whitneyfaires.com Gift: https://whitneyfaires.com/freebie/ Stalk me online! Linktr.ee: https://linktr.ee/conniewhitman Subscribe to the Changing the Sales Game Podcast on your favorite podcast streaming service or YouTube.  New episodes are posted every week - listen as Connie delves into new sales and business topics, or addresses problems you may have in your business.  

This week, we revisit our interview with Stacey Porter. Stacey is the Chief People Officer at PROCEPT BioRobotics. Prior to that, she was the Chief People Officer at Outset Medical. Stacey has expertise in organizational design, innovative talent practices, and employee engagement.  Prior to Outset, she was the Head of Global Talent Development for Intuitive Surgical, Inc., responsible for designing performance and succession practices, while developing leaders and high-performing teams. Stacey has held leadership roles at VMware and Roche, and has built a career on creating nimble, progressive organizations. She has a MSW and doctoral studies in industrial/organizational psychology.  

This week, we revisit our conversation with Keith Grossman. Keith has been a leader in the medical technology industry for more than 35 years. He was the Chairman of the Board of Nevro Corporation (NVRO) until April 2025, having previously served as President and CEO from 2019 to April 2023.  Prior to Nevro, he was named President and CEO of Thoratec Corp. (THOR) for the second time in 2014. He led the company's return to growth, a 2.5x increase in company value, and its $3.4 billion acquisition by St. Jude Medical in 2015. He previously served as the CEO, President, and Director of Conceptus, Inc. (CPTS) from 2011 to 2013, where he took the company from negative sales growth to over 20% growth, tripled EBIDTA, and led the company's sale to Bayer Healthcare for over $1.1 billion, a 3x increase in the company's value before his arrival.  Prior to Conceptus, Keith served as managing director of TPG (Texas Pacific Group), a private equity firm, as a member of its healthcare investment team. Prior to TPG, Mr. Grossman served as Thoratec's President, Chief Executive Officer, and director for the first ten years of its growth as a commercial company. Prior to Thoratec, he held a number of commercial and general management roles with companies including SulzerMedica and American Hospital Supply Corp.  He currently also serves as Vice Chairman of Alcon, Inc., and is on the board of Outset Medical, Inc. and previously served as a member of the Board of Directors of Intuitive Surgical, Inc., Kyphon, Inc., ViewRay, Inc., Zeltiq, Inc, and a number of privately held medical device companies. Keith received a B.S. in life sciences from The Ohio State University and an M.B.A. from Pepperdine University.  

Aktien hören ist gut. Aktien kaufen ist besser. Bei unserem Partner Scalable Capital geht's unbegrenzt per Trading-Flatrate und auf der hauseigenen European Investor Exchange, die genau auf Privatanleger zugeschnitten ist. Alle weiteren Infos gibt's hier: scalable.capital/oaws. VW macht Cash. MTU leidet unter GE. Beide leiden unter Erfolg. Carl Zeiss Meditec leidet unter China und Ubisoft crasht komplett. Moderna freut sich über eine Studie, Alibaba will Chip-IPO und Disco boomt. Außerdem: Zahlen von Intel. Procter & Gamble (WKN: 852062) ist und bleibt eine stabile Dividendenwette. Oder doch ein riskanter Gamble gegen Inflation, Zölle und Eigenmarken? Die wertvollste Robotik-Firma der Welt heißt Intuitive Surgical (WKN: 888024). In einer Zeit, wo Robotik der heiße Scheiß der KI-Welt ist, geht die Aktie… nirgends hin. Was da los? Wird Intuitive von Konkurrenz überrollt? Diesen Podcast vom 23.01.2026, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung.

En este análisis del mercado estadounidense, Rafael Ojeda, miembro del Comité de Inversiones de Ursus3 Capital, examina el comportamiento de los índices de Wall Street en un día de incertidumbre. Se discuten los datos del PMI manufacturero y de servicios, así como la confianza de la Universidad de Michigan. Además, se evalúa el impacto de los resultados de Intel y su decepcionante guidance, la demanda de Trump contra JP Morgan, y los despidos en Amazon. También se analiza el desempeño positivo de Intuitive Surgical y la reestructuración de FedEx en Francia. Este contenido ofrece una visión detallada de las tendencias económicas actuales y las estrategias empresariales en un entorno competitivo.

In der heutigen Folge sprechen die Finanzjournalisten Anja Ettel und Holger Zschäpitz über den 25.000-Punkte-Triumph beim Dax, Trumps Zorn über die Rüstungsbranche und eine wagemutige Berkshire-Kopie. Außerdem geht es um Nvidia, Intel, AMD, Qualcomm, Siemens, Mercedes, Hyundai, Chubb, Progressive, Union Pacific, NextEra, State Street Industrial Select SPDR ETF (WKN: A14QB3), GE Aerospace, Caterpillar und RTX, Apple, Alphabet, Coca-Cola, Bank of America, American Express, Blackstone, Invitation Homes, Chevron, Nvidia, Taiwan Semiconductor Manufacturing Company, AbbVie, Revolution Medicines, CoreWeave, CrowdStrike, Kratos Defense & Security Solutions, AeroVironment, Rocket Lab, SAP, Yaskawa Electric, Serve Robotics, Hesai, Doosan, FANUC, UiPath, Pony.ai, ABB, Intuitive Surgical, Teradyne, Aptiv, Jungheinrich, ARK Artificial Intelligence & Robotics ETF (WKN: A408AX), iShares Automation & Robotics ETF (WKN: A2ANH0), Global X Robotics & Artificial Intelligence ETF (WKN: A2QPBW), Amundi MSCI Robotics & AI ETF (WKN: A2JSC9), L&G ROBO Global Robotics and Automation ETF (WKN: A12DB1), VanEck Medical Robotics and Bionic Engineering UCITS ETF (WKN: A3DT2R), Amundi NYSE Arca Gold BUGS (WKN: ETF191) Wir freuen uns an Feedback über aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Der Börsen-Podcast Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Kevin Horner's Technical Tuesday covers the S&P 500 (SPX), Rivian (RIVN) and Intuitive Surgical (ISRG). On the S&P 500, he highlights the 50-day moving average as a place to watch and expects a bullish tilt. Rivian has a “really great report” in early November and rallied 80%, breaking $20 for the first time. Kevin points out what to watch to the upside or downside from here. He sees an ascending triangle pattern for Intuitive Surgical.======== Schwab Network ========Empowering every investor and trader, every market day.Options involve risks and are not suitable for all investors. Before trading, read the Options Disclosure Document. http://bit.ly/2v9tH6DSubscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

Alexis Garcia and Ken Shreve analyze Tuesday's market action and discuss key stocks to watch on Stock Market Today. Learn more about your ad choices. Visit megaphone.fm/adchoices

Ken Shreve and Ed Carson walk through Tuesday's market action and discuss key stocks to watch in Stock Market Today Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of The Interventional Endoscopist, I sit down with Matt Schwartz, Co-Founder and CEO of Virgo Surgical Video Solutions, a company that transforms procedural video into structured, searchable, AI-ready data. Matt shares the early spark that led him to leave Intuitive Surgical to start Virgo, the challenges of installing early systems in GI units, and how automated, zero-click video capture evolved into a massive national dataset powering the next generation of AI in endoscopy. We dive into: Why video is one of the most overlooked datasets in medicine The medicolegal reality (and why video can actually protect physicians) Foundation models for endoscopy and site-level customization The future of training, credentialing, and outcome prediction from routine colonoscopy and EGD video Leadership lessons from building a healthcare startup If you're interested in digital endoscopy, AI, clinical training, or med-tech innovation, this episode offers a look into the future of how GI will be practiced.   Helpful links referenced in the podcast https://virgosvs.com https://endoml.ai EndoDINO foundation model manuscript  

Surgical robotics is changing the landscape in healthcare. Stereotaxis is hoping to carve out its niche in the massive space, which is home to Intuitive Surgical, Johnson & Johnson, and Medtronic.David Fischel, the St. Louis, MO-based company's chairman and CEO, is featured in this episode of Let's Talk Medtech to discuss Stereotaxis' journey from surviving to thriving. The firm recently secured $50 million in funding and has had strong collaborations with NVIDIA.Fischel talks about the company's game plan and his thoughts on the future of surgical robotics.

An exclusive behind-the-scenes look at the world-famous ORSI Academy in Belgium! Declan and Renu travelled to this remarkable facility just outside Ghent in Belgium, jammed full of tens of millions of dollars worth of robotic surgery technology from the world's top providers - Intuitive Surgical, Medtronic, Microport and more. Every day, surgeons from all around the world are getting hands-on experience using the latest robotic surgery technology in an array of training environments. Plus ORSI Academy hosts many academic programs, live surgery events, telesurgery demonstrations, and is actually expanding to do even more! We get a superb tour of the building hosted by Urologist, Dr Ruben de Groote, who also tells us about Surgquest, the digital arm of ORSI Academy, which hosts an incredible library of surgical education videos, and we also chat with ORSI Academy founder and CEO, Dr Alex Mottrie, world-renowned urologist and pioneer of robotic surgery. Plus we hear first hand from senior Urology Fellows, Dr Edoardo Beatrici, and Dr Mario de Angelis, about how the ORSI Academy proficiency-based progression training works in practice. This one much better enjoyed on our YouTube channel! Links:ORSI Academy Surgquest 

"Whitney Faires an internationally recognized executive coach, keynote speaker, and leadership advisor with 20 years of experience in the healthcare industry. Formerly Chief of Staff to the CFO at Intuitive Surgical, she led high-impact organizational health initiatives, launched global leadership development programs, and coached rising professionals into senior roles. Her multifaceted career spans sales, finance, and commercial operations, where she spearheaded the creation of a $2 billion international leasing portfolio. As the founder of Whitney Faires Coaching, she developed the Courageous Leader Roadmap - a practical approach for leaders to show up authentically, navigate adversity, and drive meaningful results. She is an ICF-accredited PCC coach and is passionate about helping leaders elevate their influence and build high-performing teams.

Ken Shreve and Ed Carson analyze Tuesday's market action and discuss key stocks to watch on Stock Market Today. Learn more about your ad choices. Visit megaphone.fm/adchoices

Ken Shreve and Ed Carson analyze Wednesday's market action and discuss key stocks to watch on Stock Market Today. Learn more about your ad choices. Visit megaphone.fm/adchoices

Most professionals chase the next promotion without ever asking if it's the right move. In this conversation, Kendall Berg and executive coach Whitney Faires expose the myth of the linear career path and why the most fulfilled leaders often take strategic sideways moves instead of climbing straight up. Whitney shares her Courageous Leader Roadmap, a framework for showing up with authenticity, self-awareness, and fearless communication, the traits that separate high performers from true leaders. Together, they unpack the messy middle of leadership transitions, how to navigate corporate politics without selling your soul, and why your reputation starts forming long before you enter the room. In this episode, we discuss: What are the most overlooked skills when moving from contributor to director? How can leaders build influence without self-promotion? How do you navigate corporate politics without losing authenticity? What's the right moment to make a lateral move instead of chasing a promotion? How can specific feedback requests accelerate leadership growth? What does it mean to lead courageously — and how can you start today? What's one "corporate game" rule you've learned the hard way?

Justin Nielsen and Mike Webster analyze Friday's market action and discuss key stocks to watch on Stock Market Today. Learn more about your ad choices. Visit megaphone.fm/adchoices

Alexis Garcia and Justin Nielsen analyze Monday's market action and discuss key stocks to watch on Stock Market Today. Learn more about your ad choices. Visit megaphone.fm/adchoices

In het Meander Medisch Centrum in Amersfoort wordt deze week voor het eerst geopereerd met de Da Vinci 5, de nieuwste generatie operatierobot van Intuitive Surgical. Deze robot assisteert chirurgen bij kijkoperaties tot op een honderdste millimeter nauwkeurig en analyseert beelden achteraf met kunstmatige intelligentie. Zo kan de chirurg feedback krijgen op zijn eigen werk. Een primeur die ook vragen oproept over verantwoordelijkheid, opleiding en stress in de operatiekamer. Presentatrice Nina van den Dungen spreekt in deze aflevering met Ivo Broeders, chirurg en hoogleraar robotica bij het Meander MC, over de eerste operaties met de Da Vinci 5 en de rol van de robot in de operatiekamer. Ook te gast is Iwan van Vijfeijken, CEO van het Eindhovense Microsure, dat werkt aan een Nederlandse operatierobot voor open microchirurgie. Hun robot, de MUSA 3, maakt het mogelijk om op microschaal te opereren aan bloed- en lymfevaten. Precisiewerk dat nu slechts een klein deel van de chirurgen aankan. Verslaggever Stijn Goossens bezoekt de operatiekamers van het Meander MC, krijgt uitleg van chirurg Esther Consten en test de nieuwe Da Vinci 5-robot zelf. Wat maakt die nieuwe robot zo belangrijk? En hoe werkt het tijdens een operatie? Redactie: Stijn GoossensSee omnystudio.com/listener for privacy information.

In het Meander Medisch Centrum in Amersfoort wordt deze week voor het eerst geopereerd met de Da Vinci 5, de nieuwste generatie operatierobot van Intuitive Surgical. Deze robot assisteert chirurgen bij kijkoperaties tot op een honderdste millimeter nauwkeurig en analyseert beelden achteraf met kunstmatige intelligentie. Zo kan de chirurg feedback krijgen op zijn eigen werk. Een primeur die ook vragen oproept over verantwoordelijkheid, opleiding en stress in de operatiekamer.

Unser Partner Scalable Capital ist der einzige Broker, den deine Familie zum Traden braucht. Bei Scalable Capital gibt's nämlich auch Kinderdepots. Alle weiteren Infos gibt's hier: scalable.capital/oaws. Tesla verfehlt Erwartungen. Anthropic kauft von Google. IBM, L'Oréal, Hermès wachsen, Aktien fallen trotzdem. Kering schrumpft weniger. Teamviewer senkt Prognose. Adidas erhöht Prognose. SAP fällt wegen Cloud-Segment. 11.000 Roboter von Intuitive Surgical (WKN: 888024) operieren weltweit. Im letzten Quartal hat die Firma die Erwartungen übertroffen, doch Analysten warnen vor aufstrebenden Konkurrenten. Morgan Stanley (WKN: 885836) will seine Kryptostrategie anpassen und nicht nur Großkunden Zugang zu Bitcoin und Co. geben. Das könnte Kryptowährungen mehr Akzeptanz bringen - was bringt es der Morgan-Stanley-Aktie? Diesen Podcast vom 23.10.2025, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung.

In this episode, Scott highlights Intuitive Surgical's strong growth, GM's record quarter, Netflix's steady success, and more.

In this episode, Scott highlights Intuitive Surgical's strong growth, GM's record quarter, Netflix's steady success, and more.

Die seit gestern Abend gemeldeten Ergebnisse sind gemischt, bis leicht positive ausgefallen. Wir sehen nach den Zahlen bei insbesondere Intuitive Surgical deutliche Kursgewinne. Auch die Aktien von Capital One, GE Vernova, Hilton und AT&T tendieren nach den Ergebnissen freundlich. Abgabedruck sehen wir wegen verfehlter Ertragszahlen und belasteter Margen bei vor allem Netflix, wie auch bei Texas Instruments wegen der flauen Aussichten. Nach dem Closing werden die Ergebnisse von vor allem IBM und Tesla viel Beachtung finden. Auf der Macro-Ebene bleibt es unruhig. Donald Trump lässt offen, ob ein Treffen mit Chinas Xi am 31. Oktober tatsächlich stattfinden wird. Außerdem will Trump mit den Demokraten erst dann sprechen, wenn der Shutdown aufgehoben wird. Die Lager bleiben hier anscheinend weiter gespalten. Ein Podcast - featured by Handelsblatt. +++ Alle Rabattcodes und Infos zu unseren Werbepartnern findet ihr hier: https://linktr.ee/wallstreet_podcast +++ +++ Hinweis zur Werbeplatzierung von Meta: https://backend.ad-alliance.de/fileadmin/Transparency_Notice/Meta_DMAJ_TTPA_Transparency_Notice_-_Ad_Alliance_approved.pdf +++ Der Podcast wird vermarktet durch die Ad Alliance. Die allgemeinen Datenschutzrichtlinien der Ad Alliance finden Sie unter https://datenschutz.ad-alliance.de/podcast.html Die Ad Alliance verarbeitet im Zusammenhang mit dem Angebot die Podcasts-Daten. Wenn Sie der automatischen Übermittlung der Daten widersprechen wollen, klicken Sie hier: https://datenschutz.ad-alliance.de/podcast.html Impressum: https://www.360wallstreet.de/impressum

Die seit gestern Abend gemeldeten Ergebnisse sind gemischt, bis leicht positive ausgefallen. Wir sehen nach den Zahlen bei insbesondere Intuitive Surgical deutliche Kursgewinne. Auch die Aktien von Capital One, GE Vernova, Hilton und AT&T tendieren nach den Ergebnissen freundlich. Abgabedruck sehen wir wegen verfehlter Ertragszahlen und belasteter Margen bei vor allem Netflix, wie auch bei Texas Instruments wegen der flauen Aussichten. Nach dem Closing werden die Ergebnisse von vor allem IBM und Tesla viel Beachtung finden. Auf der Macro-Ebene bleibt es unruhig. Donald Trump lässt offen, ob ein Treffen mit Chinas Xi am 31. Oktober tatsächlich stattfinden wird. Außerdem will Trump mit den Demokraten erst dann sprechen, wenn der Shutdown aufgehoben wird. Die Lager bleiben hier anscheinend weiter gespalten. Abonniere den Podcast, um keine Folge zu verpassen! ____ Folge uns, um auf dem Laufenden zu bleiben: • X: http://fal.cn/SQtwitter • LinkedIn: http://fal.cn/SQlinkedin • Instagram: http://fal.cn/SQInstagram

Healthcare schwächelt, doch Arne Briest bleibt gelassen. Der Manager des Wikifolio Healthcare Demografie setzt weiter auf Robotik, Biotech und Medizintechnik. "Der demografische Wandel ist voll im Laufen – der Trend bleibt intakt", sagt Briest. Kurzfristige Dellen durch Trump, Kosten und Regulierung ändern für ihn nichts am Kurs: "Verwerfungen haben Vorteile - der Markt verdaut und adjustiert sich."

Dr. Vishwa Srivastava, APAC CEO of SSI, SS Innovations International, is a leader in telesurgery, using robotic surgery to extend surgical services in underserved areas. The SSI Mantra surgical robot is used for laparoscopic surgery and offers an affordable alternative to prevailing robotic solutions without compromising quality. Telesurgery has potential in remote operations and is also revolutionizing surgical training by providing real-time expert proctoring. Vishwa explains, "My father was one of the early global pioneers in robotic cardiac surgery, and he had actually helped Intuitive Surgical back in their early days get their FDA approval. And what he recognized very quickly was that through these minimally invasive robotic cardiac surgical procedures, 20% of his patients went home the next day, 50% in two days or less, and the average length of stay was 3.2 days. So, he became convinced after they twisted his arm to launch robotic cardiac surgical programs. And Dr. Fred Moll at the time was the chairman and founder of Intuitive Surgical, and he wanted to start on the heart because it was the most complex procedure to do a beating heart, totally endoscopic, bypass surgery. And he felt that if you could do that, then everything else would be simple."   "The way that we look at remote robotic surgery, or what we call telesurgery, currently, we are the only company in India that has received formal regulatory approval from the CDSCO for both teleproctoring and telesurgery. The way that we look at teleproctoring and telesurgery, it's not like one rockstar surgeon sitting in one location operating omnipresent in a hundred different locations." "With teleproctoring and telesurgery, the way that we look at it is in addition to operating and extending expertise in the remote areas of the country, we look at teleproctoring and telesurgery the same way that doctors are trained in residency where you always have an attending in the room, the junior surgeon will be operating, and the goal of the proctor or the attending surgeon is to guide the junior surgeon to maturity."  #SSInnovations #RoboticSurgery #Telesurgery #CardiacProcedures #HeartSurgery #Teleproctoring #RemoteSurgery  SSInnovations.com Download the transcript here

Dr. Vishwa Srivastava, APAC CEO of SSI, SS Innovations International, is a leader in telesurgery, using robotic surgery to extend surgical services in underserved areas. The SSI Mantra surgical robot is used for laparoscopic surgery and offers an affordable alternative to prevailing robotic solutions without compromising quality. Telesurgery has potential in remote operations and is also revolutionizing surgical training by providing real-time expert proctoring. Vishwa explains, "My father was one of the early global pioneers in robotic cardiac surgery, and he had actually helped Intuitive Surgical back in their early days get their FDA approval. And what he recognized very quickly was that through these minimally invasive robotic cardiac surgical procedures, 20% of his patients went home the next day, 50% in two days or less, and the average length of stay was 3.2 days. So, he became convinced after they twisted his arm to launch robotic cardiac surgical programs. And Dr. Fred Moll at the time was the chairman and founder of Intuitive Surgical, and he wanted to start on the heart because it was the most complex procedure to do a beating heart, totally endoscopic, bypass surgery. And he felt that if you could do that, then everything else would be simple."   "The way that we look at remote robotic surgery, or what we call telesurgery, currently, we are the only company in India that has received formal regulatory approval from the CDSCO for both teleproctoring and telesurgery. The way that we look at teleproctoring and telesurgery, it's not like one rockstar surgeon sitting in one location operating omnipresent in a hundred different locations." "With teleproctoring and telesurgery, the way that we look at it is in addition to operating and extending expertise in the remote areas of the country, we look at teleproctoring and telesurgery the same way that doctors are trained in residency where you always have an attending in the room, the junior surgeon will be operating, and the goal of the proctor or the attending surgeon is to guide the junior surgeon to maturity."  #SSInnovations #RoboticSurgery #Telesurgery #CardiacProcedures #HeartSurgery #Teleproctoring #RemoteSurgery  SSInnovations.com Listen to the podcast here

In der heutigen Folge sprechen die Finanzjournalisten Anja Ettel und Holger Zschäpitz über einen Gamechanger-Deal, Wall-Street-Rekorde trotz Shutdown und das fulminante Börsendebüt von Fermi. Außerdem geht es um Pfizer, Merck, Eli Lilly, Novo Nordisk, Vertex, Regeneron, Thermo Fisher, Repligen, Danaher, Boston Scientific, Abbott, Intuitive Surgical, Bayer, Merck, Salzgitter, Thyssenkrupp, Bitcoin, Solana, Ether, Sartorius, Palantir Technologies, Thales, L3Harris Technologies, RTX, Kratos Defense & Security Solutions, AeroVironment, DroneShield, Elbit Systems, Electro Optic Systems, Saab AB, Hensoldt, Mercury Systems, QinetiQ, Chemring Group, Cohort, Exail Technologies, Rocket Lab, Iridium Communications, BlackSky Technology, Electro Optic Systems, Leidos Holdings, CACI International, Parsons, Telos Corp, Leidos, SAIC, QinetiQ, Parsons VanEck Space Innovators ETF (WKN: A3DP9J), Invesco Defence Innovation ETF (WKN: A40J95), Global X Defence Tech ETF (WKN: A40E7A), Droneshield, Palantir, Red Cat Holdings. Wir freuen uns über Feedback an aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Der Börsen-Podcast Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article104636888/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

What separates good managers from leaders people line up to work for? In this energizing conversation, host Anusha sits down with Whitney Faires—internationally recognized coach, keynote speaker, and former senior executive at Intuitive Surgical who helped scale a $2B business line—to unpack the Courageous Leader Roadmap. Whitney shares the “Sunday-night test” for honest self-assessment, explains why people-first leadership outperforms results-only management, and reframes fearless communication as a practice of refusing to let fear decide what gets said—not saying everything that crosses your mind.You'll learn how to identify your leadership archetype, build judgment and self-awareness in high-stakes moments, and consistently access your power zone using personal activators (and guarding against depletors). Whitney also talks candidly about navigating guilt, competing priorities, and career pivots you didn't choose—plus how to reclaim agency by focusing on what you can control and designing growth inside any role.Whether you're managing your first team or scaling a division, this episode gives you practical prompts, mindset shifts, and repeatable routines to raise your game—and your team's.Connect with Whitney on LinkedIn or Instagram (@whitney_faires) and join her mailing list for upcoming workshops and group coaching opportunities.Thank you to Gies College of Business for Sponsoring this Podcast. Want to be considered for the podcast? Send an email to ashton@ellevatenetwork.com with your topic focus and a short bio.To learn more about Ellevate Network and how we're building a community that supports women+ at every stage of their careers, visit ellevatenetwork.com or reach out to info@ellevatenetwork.com.

This week, we revisit our conversation with Keith Grossman. Keith has been a leader in the medical technology industry for more than 35 years. He was the Chairman of the Board of Nevro Corporation (NVRO) until April 2025, having previously served as President and CEO from 2019 to April 2023. Prior to Nevro, he was named President and CEO of Thoratec Corp. (THOR) for the second time in 2014. He led the company's return to growth, a 2.5x increase in company value, and its $3.4 billion acquisition by St. Jude Medical in 2015. He previously served as the CEO, President, and Director of Conceptus, Inc. (CPTS) from 2011 to 2013, where he took the company from negative sales growth to over 20% growth, tripled EBIDTA, and led the company's sale to Bayer Healthcare for over $1.1 billion, a 3x increase in the company's value before his arrival. Prior to Conceptus, Keith served as managing director of TPG (Texas Pacific Group), a private equity firm, as a member of its healthcare investment team. Prior to TPG, Mr. Grossman served as Thoratec's President, Chief Executive Officer, and director for the first ten years of its growth as a commercial company.  Prior to Thoratec, he held a number of commercial and general management roles with companies including SulzerMedica and American Hospital Supply Corp. He currently also serves as Vice Chairman of Alcon, Inc., and is on the board of Outset Medical, Inc. and previously served as a member of the Board of directors of Intuitive Surgical, Inc., Kyphon, Inc., ViewRay, Inc., Zeltiq, Inc, and a number of privately held medical device companies. Keith received a B.S. in life sciences from The Ohio State University and an M.B.A. from Pepperdine University.

Miguel Méndez, analista de mercados ha analizado la situación del mercado. Sobre Iberdrola, Méndez ha sido claro: “Me está aburriendo un poco últimamente”. En contraste, ha señalado que Endesa le está gustando más actualmente por su comportamiento en el mercado. En cuanto a valores estadounidenses, ha dicho que Ulta Beauty, “lo está haciendo muy bien” y actualmente se encuentra “testeando la resistencia” tras superar un largo periodo bajista de casi dos años. Por otra parte, Intuitive Surgical fue uno de los nombres destacados del consultorio: “Tienen algo que prácticamente es único en el mercado. En el ámbito nacional, Banco Sabadell también fue protagonista. Méndez ha sido tajante: “He escuchado esta mañana al CEO de Sabadell y yo, si fuese inversor, vendería las acciones”, pese a que el valor se ha multiplicado por 10 o 12 desde 2020. Por último, ha mostrado una visión positiva sobre Repsol, asegurando que “lo ha hecho muy bien” y que, lejos de recomendar su venta, sugiere mantenerla en cartera con un stop en los 13,90 euros.

Find out who our gold, silver, and bronze winners are this week. We'll take a look at earnings from General Motors, Intuitive Surgical, and Enphase Energy, and we will also discuss the recent tariff deal struck between the US and Japan. Companies mentioned: GM, ISRG, ENPH Host: Travis Hoium Guests: Lou Whiteman, Matt Frankel Learn more about your ad choices. Visit megaphone.fm/adchoices

Welcome to a new episode of the EUVC podcast, where Dan Bowyer and Mads Jensen of SuperSeed and Lomax from Outsized Ventures, gather to unpack the macro forces and micro signals shaping European tech and venture.This week, the trio tackles one of the most geopolitically charged, capital-heavy, and morally complex episodes yet:

Welcome to a new episode of the EUVC podcast, where Dan Bowyer and Mads Jensen of SuperSeed and Lomax from Outsized Ventures gather to unpack the macro forces and micro signals shaping European tech and venture.This week, the trio tackles one of the most geopolitically charged, capital-heavy, and morally complex episodes yet:The global reshuffling of power: Israel, Iran, Russia, and UkraineWhy defense is back—and what it means for VCsEurope's space ambitions and what the ESA's new satellite project signalsChina's trade plays and Europe's vulnerability in rare earthsAI, IPOs, and why founders might want to stay private longerSurgical robots, ambient AI, and who's building the future of healthcarePlus: Daniel Ek gets flak, SPACs sneak back, and why VCs are now speed-running $15B deals in one week.Here's what's covered:02:00 War & Markets: Iran, Israel, oil prices & Bank of England holds06:00 Defense Budgets: Why Europe is (finally) spending10:00 VC Taboo: Why investing in weapons gets complicated fast15:00 EIF Restrictions: Sex, gambling, and no defense20:00 The Rise of Helsing: Europe's $12B defense unicorn24:00 Strategic Autonomy: Europe's new military satellite constellation30:00 ESA vs. Starlink: Earth observation gets serious34:00 China, Trade Wars & Rare Earths: Why Europe's exposed40:00 EU-US Tariffs & Trump's Pharma Threat42:00 IPO Boom: Chime, Circle, and the SPAC comeback47:00 CMR Surgical: UK's $4B robot exit—is that enough?53:00 Lessons from Intuitive Surgical & deeptech M&A56:00 Deal of the Week: Nabla's AI for clinicians, Helsing, and Scale AI's lightning-fast cash01:02:00 Founders in Government: Alex DePledge & Matt Clifford's impact01:05:00 Meta's AI Transfers: Zuck goes full football transfer window

Whitney Faires is an internationally recognized coach, keynote speaker, and leadership strategist who empowers her clients to overcome obstacles and achieve extraordinary levels of performance with greater fulfillment. She spent 16 years at Intuitive Surgical, where she led global leadership development and helped scale a $2B business line. Now she helps high achievers—especially those ready for something more—pivot into values-aligned leadership roles with clarity and confidence. A leading authority in developing high-performing teams and coaching industry executives worldwide, she focuses on helping people master their mindset to unlock their full potential and thrive both personally and professionally. In this episode Whitney and Christa cover the importance of personal growth, overcoming self-doubt, and the significance of building a supportive network! Website: whitneyfaires.com LinkedIn: https://www.linkedin.com/in/whitney-faires-14955a38/ Instagram: @whitney_faires Keywords: coaching, personal development, self-doubt, career transition, support network, entrepreneurship, leadership, empowerment, growth, mentorship Takeaways: **Whitney transitioned from a corporate career to coaching to fulfill her passion for helping others grow. **High performers often seek more than just financial success; they crave impact and fulfillment. **Creating a supportive environment is crucial for pe achieving your career goals. **Building a business while still employed can provide the confidence needed to make a career leap. **It's essential to have a clear plan and understanding of your value before transitioning careers. **Mentorship and accountability are vital for navigating career changes successfully. **Follow-through on commitments to mentors is crucial for maintaining valuable relationships. **Finding the right fit with a coach or mentor can significantly impact your growth journey. Chapters 00:00 The Journey to Coaching: A Personal Transformation 12:03 Overcoming Self-Doubt and Embracing Change 18:11 Building a Supportive Network and Finding Your Tribersonal and professional growth.

If your doctor is recommending that you get a mastectomy, you will likely have some choices about how the surgery is performed. Your breast cancer treatment, your body, your breast shape and your lifestyle affect not only your options, but also the pros and cons of your options. There's no one method that works best for everyone because each person is unique. Today we are going to be exploring one specific type of mastectomy – the nipple-sparing mastectomy. This is a skin-sparing mastectomy that leaves the nipple and areola intact and usually improves the overall look of the reconstructed breast. Joining us on the show today are two very special guests: Dr. Mara Piltin, a Breast and Melanoma Surgical Oncologist and Physician Assistant, Maddie Beiswanger, both from Mayo Clinic. They are going to tell us more about nipple-sparing mastectomy procedures, current research that is being conducted around the use of minimally invasive robotic surgery to assist in these procedures and the possible benefits that these innovations can provide. This episode of The Real Pink Podcast is brought to you by Intuitive Surgical. Intuitive is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. Intuitive has been advancing minimally invasive care since 1995 with the goal of helping physicians improve the lives of people around the world. You can learn more at www.Intuitive.com

Alphabet's ad business keeps putting up huge numbers, but a DOJ breakup, generative AI threats, and potential macro slowdown loom. (00:21) Jason Moser and Asit Sharma discuss: - Alphabet's resilient ad business, and what parts of the company might be most interesting if the break-up happens. - Tesla's rough quarter, and why the Model Y release is a key moment for the company's auto thesis. - Chipotle's burrito slowdown, how ServiceNow's government contracts are holding up, and the latest with Intuitive Surgical. (19:11) Malcolm Ethridge comes back on the show to talk big tech and his favorite recession-proof stocks. (34:48) Asit and Jason break down two stocks on their radar: Nasdaq and Adobe. Stocks discussed: GOOG, GOOGL, TSLA, NOW, ISRG, ACN, NFLX, SPOT, NDAQ, ADBE. Host: Dylan Lewis Guests: Jason Moser, Asit Sharma, Malcolm Ethridge Engineers: Dan Boyd Learn more about your ad choices. Visit megaphone.fm/adchoices

Follow along and subscribe/rate/review at https://www.briancovey.com/podcast/In this episode of The Competitive Edge, Brian Covey welcomes high-performance coach Kristy Kuhl, whose journey from a one-stoplight town to corporate sales superstar and now elite coach serves as a blueprint for self-alignment and transformation.Kristy shares her transition from the high-stress world of medical device sales — notably with Intuitive Surgical's da Vinci robot — to a more purpose-driven life centered on coaching. Her story is a powerful reminder that success without alignment can lead to burnout. Kristy introduces listeners to the power of Human Design, situational leadership, and the role of fitness in mental clarity and peak performance.Together, Brian and Kristy unpack strategies for building self-awareness, curating your circle of influence, and creating a life and career in sync with your values. From navigating social media with intention to developing platforms that serve others authentically, this episode is packed with tools and takeaways for leaders, entrepreneurs, and anyone ready to grow.Tune in for an inspiring and practical conversation that will challenge you to look inward, take aligned action, and surround yourself with the right people to elevate your game.

  During this Episode, Russ discusses the Large Unprotected Covered Call or L.U.C.C trading strategy.  Large in that the share price is large (think Costco, Netflix, Intuitive Surgical, etc.).  Unprotected in the sense that the strategy doesn't buy insurance in  a protective put option at a lower price (like a collar trade).  It is essentially a large, In The Money (“ITM”) covered call.  It is protected from volatility and the large upfront cost by how far down in the money you select, and you give back some of the premium (the intrinsic value portion) - though give back is a misnomer in that it all happens automatically at the brokerage.  Several examples are given.    Don't forget to subscribe to the show!

Get 25% off an annual membership with this link: https://ko-fi.com/chipstockinvestor/link/MARKETMELTDOWN25In this episode of Chip Stock Investor, we dive into fresh earnings reports from two robotics-heavyweights: Tesla and Intuitive Surgical. Is Tesla's Q1 dip a normal cycle downturn or the start of something bigger? We explore key data points like vehicle deliveries, energy revenue, and Elon's political impact. Then we turn to Intuitive Surgical's solid performance, procedure growth, and how tariffs might affect its margins. Two very different businesses, both navigating big challenges and big opportunities.Sign Up For Our Newsletter: https://mailchi.mp/b1228c12f284/sign-up-landing-page-short-formJoin us on Discord with Semiconductor Insider: https://ko-fi.com/chipstockinvestor/tiersSupercharge your analysis with AI! Get 15% of your membership with our special link here: https://finchat.io/csi/Safeguard your personal information with Aura's monitoring service – try it free for two weeks and see where your data might be lurking: https://aura.com/chipstockinvestor

Carson Group's Ryan Detrick and Payne Capital's Courtney Garcia break down today's huge rally, with the major averages regaining all of Monday's big losses. A packed slate of earnings led by Tesla. Wedbush's Dan Ives and former Tesla President Jon McNeill give instant reaction to the EV-maker's numbers. On the macro front, Jefferies' David Zervos discusses Fed policy and the latest Trump vs. Powell tensions. Other earnings include Enphase, Baker Hughes, Capital One, Intuitive Surgical and SAP. Plus, Morgan gives key takeaways from defense sector earnings. 

In this episode of Medsider Radio, we sat down with Ryan Rhodes, CEO of EDAP TMS. EDAP is changing prostate cancer treatment through Focal One, a robotic high-intensity focused ultrasound (HIFU) system that doesn't require the use of surgery or radiation. Ryan has over 30 years of experience in market development, with two decades focused on medical robotics. Before EDAP, Ryan was CEO of Restoration Robotics, where he guided the company to a successful merger with Venus Concept. He spent 13+ years at Intuitive Surgical, establishing the global Urology franchise, which became the company's entry point for broader adoption of the da Vinci system. He also spent 11 years at Ethicon (J&J) in sales, marketing, and market development.In this interview, Ryan challenges founders to ask: Are you creating a scalable medtech solution or a product with limited growth potential? He unpacks why standardization and scalability are critical for adoption, how clinical data fuels credibility and reimbursement, and why early adopters take the biggest risks — but also reap the biggest rewards.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Ryan Rhodes.

In this week's Digital Health Roundup, Medtech Insight's Marion Webb highlights her interview with Gary Guthart, CEO of Intuitive Surgical about the new da Vinci 5 surgical robot and the future of robotics in surgery. Brian Bossetta talks about the recently FDA-cleared patient monitoring system that sends vital signs directly to clinician staff. Elizabeth Orr discusses an FDA warning letter to Exer Labs and Shubham Singh discusses Roche's new NGS Prototype, expected to challenge Illumina.

Eric Veiel, head of Global Investments and CIO at T. Rowe Price Associates, chats with Gary Guthart, CEO of Intuitive Surgical, about advancements in robotic surgery, the company's expanding ecosystem, and his journey to becoming CEO.

On the first call since Kroger CEO Rodney McMullen's departure, not a mention of the former CEO was heard. (00:21) Nick Sciple and Ricky Mulvey discuss: - Kroger's business results. - Why some investors are becoming more pessimistic about Abercrombie & Fitch. - A small-cap tobacco company playing in a fast-growing trend. Then, (17:22) Karl Thiel joins Mary Long to discuss advanced-robotics company, Intuitive Surgical. Companies discussed: KR, ANF, TPB, ISRG, GOOG, GOOGL Host: Ricky Mulvey Guests: Nick Sciple, Mary Long, Karl Thiel Engineers: Dan Boyd, Rick Engdahl Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Scott Becker examines the struggles of major healthcare stocks like HCA, Universal Health Services, and Intuitive Surgical amid concerns over healthcare reimbursement and cost containment.

In this episode, Scott Becker discusses the latest successes of Apple, Amazon, and Intuitive Surgical, highlighting strong performances under exceptional leadership. From Apple’s record revenues to Amazon’s impressive earnings and Intuitive’s standout growth, Scott shares insights on what makes these CEOs and companies ones to watch.

In this episode, Scott Becker covers Netflix’s impressive turnaround, Intuitive Surgical’s strong performance, CVS’s CEO change and stock dip, and American Express’s slight drop despite a strong year. Listen for insights on these key market moves and more.

In this episode, Scott discusses stock performance of major companies like Macy’s, Intuitive Surgical, and Tempus AI, alongside insights into job cuts at big names like Cisco and Google. Plus, a look at the delicate balance of inflation control, strategic business advice, and more.